Last edition
News about Global Pharma
This latest investment brings the total raised by the company to EUR 3.45 million.
Global Pharma | 14/05/2024 | By Abha | 858
AbbVie Partners with Gilgamesh Pharmaceuticals to Develop Therapies for Psychiatric Disorders
AbbVie has signed an option-to-license agreement with Gilgamesh Pharmaceuticals to develop next-generation therapies for psychiatric disorders.
Global Pharma | 14/05/2024 | By Aishwarya | 821
Biocon Signs Semi-Exclusive Distribution and Supply Deal for with Medix
Biocon Ltd. has signed a semi-exclusive distribution and supply agreement with Medix, a specialty pharmaceutical company in Mexico, for the commercialization of its vertically integrated drug product, Liraglutide (gSaxenda).
Global Pharma | 13/05/2024 | By Aishwarya | 354
Geneticist Mary Dickinson Joins The Jackson Laboratory as Chief Scientific Officer
In her new role, Dr. Dickinson will spearhead JAX's research endeavors, directing scientific strategy and operations to leverage the institution's unique strengths in genetics and genomics.
Global Pharma | 13/05/2024 | By Abha | 732
Terumo BCT Receives FDA Clearance for Innovative Rika Plasma Donation System with iNomi Nomogram
This development marks a key advancement in plasma collection technology, allowing for the determination of plasma collection volume based on an individual donor's height, weight, and hematocrit level at the time of donation.
Global Pharma | 13/05/2024 | By Abha | 2109
Sanofi Invests EUR 1 Billion in France to Expand its Biomanufacturing Sites
Sanofi has made an investment of more than EUR 1 billion to create new bioproduction capacity at its sites in Vitry-sur-Seine (Val de Marne), Le Trait (Seine-Maritime) and Lyon Gerland (Rhône).
Global Pharma | 13/05/2024 | By Aishwarya | 1243
The Company continues to expect a decision regarding its 510(k) clearance in July 2024.
Global Pharma | 10/05/2024 | By Manvi | 619
Aardvark Therapeutics Secures USD 85 Million Oversubscribed Series C Financing
Aardvark Therapeutics, Inc. has received an USD 85 million oversubscribed Series C financing led by Decheng Capital.
Global Pharma | 10/05/2024 | By Aishwarya | 457
SN Bioscience's SNB-101 Granted FDA Fast Track Designation for Small Cell Lung Cancer Treatment
SNB-101, previously designated as an orphan drug for SCLC and pancreatic cancer, has now received Fast Track designation, signaling a step towards potential commercialization following the completion of phase 2 clinical trials.
Global Pharma | 10/05/2024 | By Abha | 654
WestGene's mRNA Therapeutic Cancer Vaccine Receives FDA Approval
This approval marks a key moment as the world's first EB virus-related mRNA therapeutic cancer vaccine to receive regulatory clearance.
Global Pharma | 10/05/2024 | By Abha | 905
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy